ATE524433T1 - Trpv1 agonisten , zubereitungen die diese enthalten und ihre anwendung - Google Patents
Trpv1 agonisten , zubereitungen die diese enthalten und ihre anwendungInfo
- Publication number
- ATE524433T1 ATE524433T1 AT05770295T AT05770295T ATE524433T1 AT E524433 T1 ATE524433 T1 AT E524433T1 AT 05770295 T AT05770295 T AT 05770295T AT 05770295 T AT05770295 T AT 05770295T AT E524433 T1 ATE524433 T1 AT E524433T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- preparations containing
- trpv1 agonists
- hydrogen
- trpv1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
- C07C303/44—Separation; Purification
- C07C303/46—Separation; Purification from by-products of refining mineral oils with sulfuric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001566A ITMI20041566A1 (it) | 2004-07-30 | 2004-07-30 | "trpv1 agonisti, formulazioni che li contengono e loro usi" |
PCT/EP2005/007292 WO2006010445A1 (en) | 2004-07-30 | 2005-07-06 | Trpv1 agonists, formulations containing them and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE524433T1 true ATE524433T1 (de) | 2011-09-15 |
Family
ID=34979120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05770295T ATE524433T1 (de) | 2004-07-30 | 2005-07-06 | Trpv1 agonisten , zubereitungen die diese enthalten und ihre anwendung |
Country Status (19)
Country | Link |
---|---|
US (1) | US7429673B2 (de) |
EP (1) | EP1773757B1 (de) |
JP (1) | JP4819810B2 (de) |
KR (1) | KR101206571B1 (de) |
CN (1) | CN101006047B (de) |
AT (1) | ATE524433T1 (de) |
AU (1) | AU2005266684B2 (de) |
CA (1) | CA2575341C (de) |
DK (1) | DK1773757T3 (de) |
ES (1) | ES2370029T3 (de) |
HK (1) | HK1105947A1 (de) |
IL (1) | IL181024A (de) |
IT (1) | ITMI20041566A1 (de) |
NO (1) | NO338341B1 (de) |
PL (1) | PL1773757T3 (de) |
PT (1) | PT1773757E (de) |
RU (1) | RU2379282C2 (de) |
SI (1) | SI1773757T1 (de) |
WO (1) | WO2006010445A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20080145A1 (es) | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
PE20091102A1 (es) | 2007-12-17 | 2009-07-25 | Janssen Pharmaceutica Nv | Moduladores imidazolo-, oxazolo-, y tiazolopirimidina del trpv1 |
KR101034300B1 (ko) * | 2008-12-02 | 2011-05-16 | 고려대학교 산학협력단 | Trpv3 활성 억제 약물 및 이의 활용 |
KR101034299B1 (ko) * | 2008-12-02 | 2011-05-16 | 고려대학교 산학협력단 | Trpv3 활성 조절 약물 및 이의 활용 |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
CA3027255C (en) | 2009-07-10 | 2022-06-21 | The General Hospital Corporation | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
US20120295942A1 (en) | 2010-02-01 | 2012-11-22 | Nicholas James Devereux | Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists |
AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
EP2531490B1 (de) | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexylamidderivate als crf-rezeptorantagonisten |
US10327467B2 (en) | 2010-04-14 | 2019-06-25 | Altria Client Services Llc | Preformed smokeless tobacco product |
HUE035134T2 (en) | 2010-07-27 | 2018-05-02 | Flex Pharma Inc | Methods and compositions for preventing and relieving muscle cramps and recovering from post-exercise neuromuscular excitability and fatigue |
US10799548B2 (en) * | 2013-03-15 | 2020-10-13 | Altria Client Services Llc | Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products |
RU2018107695A (ru) | 2015-08-03 | 2019-09-05 | Президент Энд Феллоуз Оф Гарвард Колледж | Заряженные блокаторы ионных каналов и способы их применения |
WO2018136943A1 (en) | 2017-01-23 | 2018-07-26 | Flex Pharma, Inc. | Compositions and methods affecting exercise performance |
MA55311A (fr) | 2019-03-11 | 2022-01-19 | Nocion Therapeutics Inc | Bloqueurs de canaux ioniques chargés et procédés d'utilisation |
US10786485B1 (en) | 2019-03-11 | 2020-09-29 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
KR20210143791A (ko) | 2019-03-11 | 2021-11-29 | 녹시온 테라퓨틱스 인코포레이티드 | 하전된 이온 채널 차단제 및 사용 방법 |
KR20210145164A (ko) | 2019-03-11 | 2021-12-01 | 녹시온 테라퓨틱스 인코포레이티드 | 에스테르 치환된 이온 채널 차단제 및 사용 방법 |
CN114828845A (zh) | 2019-11-06 | 2022-07-29 | 诺西恩医疗公司 | 带电的离子通道阻滞剂及其使用方法 |
US10933055B1 (en) | 2019-11-06 | 2021-03-02 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
EP4118070A4 (de) | 2020-03-11 | 2024-04-10 | Nocion Therapeutics Inc | Geladene ionenkanalblocker und verfahren zur verwendung |
RU2755206C1 (ru) | 2020-05-20 | 2021-09-14 | Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) | Средство пролонгированного анальгетического действия и лекарственный препарат на его основе |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4493848A (en) * | 1983-07-14 | 1985-01-15 | The Procter & Gamble Company | Compositions and methods useful for producing analgesia |
FR2619810B1 (fr) * | 1987-09-02 | 1990-01-05 | Hoechst France | Nouveaux monomeres ethyleniques polyfonctionnels |
IT1302264B1 (it) * | 1998-09-24 | 2000-09-05 | Innovet Italia Srl | Derivati a struttura n-acil vanillinamidica in grado di attivare irecettori periferici dei cannabinoidi |
JP2004182674A (ja) * | 2002-12-05 | 2004-07-02 | Kureha Chem Ind Co Ltd | バニリル脂肪酸アミドを含む抗腫瘍医薬組成物 |
-
2004
- 2004-07-30 IT IT001566A patent/ITMI20041566A1/it unknown
-
2005
- 2005-07-06 DK DK05770295.3T patent/DK1773757T3/da active
- 2005-07-06 US US11/658,737 patent/US7429673B2/en not_active Expired - Fee Related
- 2005-07-06 EP EP05770295A patent/EP1773757B1/de not_active Not-in-force
- 2005-07-06 AU AU2005266684A patent/AU2005266684B2/en not_active Ceased
- 2005-07-06 AT AT05770295T patent/ATE524433T1/de active
- 2005-07-06 KR KR1020077001812A patent/KR101206571B1/ko not_active IP Right Cessation
- 2005-07-06 CA CA2575341A patent/CA2575341C/en not_active Expired - Fee Related
- 2005-07-06 RU RU2007103344/04A patent/RU2379282C2/ru not_active IP Right Cessation
- 2005-07-06 PT PT05770295T patent/PT1773757E/pt unknown
- 2005-07-06 CN CN2005800256040A patent/CN101006047B/zh not_active Expired - Fee Related
- 2005-07-06 WO PCT/EP2005/007292 patent/WO2006010445A1/en active Application Filing
- 2005-07-06 SI SI200531416T patent/SI1773757T1/sl unknown
- 2005-07-06 ES ES05770295T patent/ES2370029T3/es active Active
- 2005-07-06 JP JP2007522950A patent/JP4819810B2/ja not_active Expired - Fee Related
- 2005-07-06 PL PL05770295T patent/PL1773757T3/pl unknown
-
2007
- 2007-01-29 NO NO20070531A patent/NO338341B1/no not_active IP Right Cessation
- 2007-01-29 IL IL181024A patent/IL181024A/en not_active IP Right Cessation
- 2007-10-17 HK HK07111192.6A patent/HK1105947A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20070531L (no) | 2007-04-30 |
IL181024A0 (en) | 2007-07-04 |
RU2007103344A (ru) | 2008-08-10 |
AU2005266684B2 (en) | 2012-05-10 |
US20080132573A1 (en) | 2008-06-05 |
HK1105947A1 (en) | 2008-02-29 |
NO338341B1 (no) | 2016-08-08 |
CN101006047B (zh) | 2010-08-11 |
JP4819810B2 (ja) | 2011-11-24 |
ES2370029T3 (es) | 2011-12-12 |
AU2005266684A1 (en) | 2006-02-02 |
RU2379282C2 (ru) | 2010-01-20 |
JP2008508202A (ja) | 2008-03-21 |
CN101006047A (zh) | 2007-07-25 |
EP1773757A1 (de) | 2007-04-18 |
KR101206571B1 (ko) | 2012-11-29 |
PT1773757E (pt) | 2011-10-27 |
PL1773757T3 (pl) | 2012-02-29 |
IL181024A (en) | 2011-12-29 |
ITMI20041566A1 (it) | 2004-10-30 |
KR20070039078A (ko) | 2007-04-11 |
WO2006010445A1 (en) | 2006-02-02 |
EP1773757B1 (de) | 2011-09-14 |
US7429673B2 (en) | 2008-09-30 |
CA2575341A1 (en) | 2006-02-02 |
DK1773757T3 (da) | 2011-11-21 |
SI1773757T1 (sl) | 2011-12-30 |
CA2575341C (en) | 2014-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE524433T1 (de) | Trpv1 agonisten , zubereitungen die diese enthalten und ihre anwendung | |
RS39704A (sr) | Novi 1,2,4-tiadiazolijum derivati kao modulatori melanokortinskog receptora | |
BRPI0507495A (pt) | composto, composição farmacêutica, uso do composto método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5 | |
TNSN02012A1 (fr) | Derives de pyrimidine nouveaux inhibiteurs de mmp, et compositions les contenant | |
MX2007008308A (es) | Derivados de n-(heteroaril)-1h-indol-2-carboxamidas y su utilizacion como ligandos del receptor vaniloide trpv1-. | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
TW200732339A (en) | Nitrogen-containing bicyclic heteroaryl compounds and methods of use | |
HUP0302960A2 (hu) | Kemokinreceptorhoz kötődő heterociklusos vegyületek, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
NO20060324L (no) | [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni | |
NO20050065L (no) | Kjemiske forbindelser | |
TNSN05073A1 (fr) | Quinazolinones spirocondensees nouvelles et leur utilisation comme inhibiteurs de phosphodiesterase | |
DE602004012758D1 (de) | Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung | |
ATE431345T1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
MA27930A1 (fr) | Derives de nicotinamide utiles comme inhibiteurs de pde4 | |
NO20064238L (no) | Imidazolinderivater med CB1 agonistlsk aktivitet | |
ATE445617T1 (de) | Chinolinderivat, dessen verwendung, herstellung und dieses enthaltendes arzneimittel | |
BRPI0409376A (pt) | derivados de indeno como agentes farmacêuticos | |
GB0512284D0 (en) | Organic compounds | |
DE602006010702D1 (de) | Homomorpholinoxazolidinone als antibakterielle mittel | |
HUP0201302A2 (hu) | IL-8 receptor antagonista ciklusos guanidinszármazékok | |
SE0403118D0 (sv) | New compounds 2 | |
SE0403117D0 (sv) | New compounds 1 | |
ATE374751T1 (de) | 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern | |
ATE340175T1 (de) | Imidazo(4,5-böchinolinderivate und ihre verwendung als inhibitoren der induzierbaren no- synthase | |
TH87428B (th) | สารประกอบชนิดใหม่ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1773757 Country of ref document: EP |